Guillard N, Spaulding C, Funck F, Py A, Chalet Y, Thebault B, Chauveau M, Guérin F
Service de cardiologie hôpital R. Dubos, Pontoise.
Arch Mal Coeur Vaiss. 1997 Oct;90(10):1349-55.
The aim of this study was to assess prospectively the feasibility, safety and quality of coronary angiography performed by a left radial arterial approach. The investigation was performed under local anesthesia with a Lidocaine gel using Judkins 5f catheter. A bolus of heparin was injected intravenously at the start of the procedure (no heparin in phase 0.2 to 3.000 IU during phase 1 and 5.000 IU in phase 2). Between March 1994 and January 1996, after exclusion of 108 patients (15.1%) mainly because of an abnormal Allen test, coronary angiography was carried out in 540 patients aged 58.4 +/- 11.7 years, 85% of whom were men. The failure rate was 8%. The quality of opacification of the left coronary artery (scale 1 to 3) was 2.91 +/- 0.27 and of the right coronary artery was 2.96 +/- 0.18. There were no complications during the procedure. Analysis of the learning curve showed a failure rate decreasing to less than 5% after 60 procedures/operator. In the last 100 procedures, the failure rate fell to 3%, the canulation time was 2.2 +/- 2.5 min, the duration of fluoroscopy was 6.5 +/- 3.9 min and the duration of the procedure was 17.5 +/- 4.7 min (14.7 +/- 3.8 min, p < 0.01, by the femoral approach). Clinical and Doppler ultrasonographic follow-up revealed one in-hospital complication (a spontaneously regressive compressive haematoma). No clinical complications were observed at 3 months. Doppler ultrasonography showed the radial artery occlusion rate to be 71% in phase 0.32% in phase 1 and 3.2% in phase 2 (p < 0.0001). These results show that the left radial arterial approach for coronary angiography is safe and effective but requires a period of training. A 5.000 IU dose of heparin limits the risk of radial artery occlusion to 3%. The absence of complications in this large series which included the training period and the patient comfort suggest that this technique may be an excellent alternative to the femoral approach and especially the brachial approach when the Allen test is normal.
本研究旨在前瞻性评估经左桡动脉途径进行冠状动脉造影的可行性、安全性及质量。研究采用利多卡因凝胶局部麻醉,使用Judkins 5f导管进行操作。在操作开始时静脉注射一剂肝素(第1阶段不使用肝素,第2阶段使用3000 IU,第3阶段使用5000 IU)。1994年3月至1996年1月期间,排除108例患者(15.1%),主要原因是艾伦试验异常,对540例年龄为58.4±11.7岁的患者进行了冠状动脉造影,其中85%为男性。失败率为8%。左冠状动脉造影剂充盈质量(1至3级)为2.91±0.27,右冠状动脉为2.96±0.18。操作过程中无并发症发生。学习曲线分析显示,每位操作者在完成60例操作后,失败率降至5%以下。在最后100例操作中,失败率降至3%,插管时间为2.2±2.5分钟,透视时间为6.5±3.9分钟,操作总时长为17.5±4.7分钟(经股动脉途径为14.7±3.8分钟,p<0.01)。临床及多普勒超声随访发现1例院内并发症(自发性消退的压迫性血肿)。3个月时未观察到临床并发症。多普勒超声显示,第0阶段桡动脉闭塞率为71%,第1阶段为32%,第2阶段为3.2%(p<0.0001)。这些结果表明,经左桡动脉途径进行冠状动脉造影安全有效,但需要一段时间的培训。5000 IU剂量的肝素可将桡动脉闭塞风险限制在3%。该大型系列研究(包括培训阶段)未出现并发症且患者舒适度良好,表明当艾伦试验正常时,该技术可能是股动脉途径尤其是肱动脉途径的极佳替代方法。